A client who is receiving sodium polystyrene sulfonate reports having two watery stools since starting the medication the previous day. Which action should the practical nurse (PN) take?

A. Report the liquid stool to the healthcare provider: While unusual or severe diarrhea may require notification, mild watery stools are an expected effect of sodium polystyrene sulfonate as it promotes potassium excretion. Immediate reporting is not necessary unless dehydration or electrolyte imbalance occurs. B. Withhold the medication until the diarrhea stops: Holding the medication is not indicated for mild, expected watery stools. Interrupting therapy could delay potassium removal and compromise the client’s treatment plan. C. Recommend that the client increase fiber in the diet: Increasing dietary fiber does not counteract the expected laxative effect of sodium polystyrene sulfonate and may not be appropriate for all clients, particularly those on restricted diets or with other comorbidities. D. Explain that this is a desired effect of the medication: Sodium polystyrene sulfonate works by exchanging sodium for potassium in the intestines, resulting in softer or watery stools. Educating the client about this expected outcome helps reduce anxiety and supports adherence to therapy.